Germany Now Covers Digital Therapies for Dementia Through Insurance

German health insurers are now covering the costs of certified digital therapies for people with mild cognitive impairment or early-stage dementia. These programs, known as Digitale Gesundheitsanwendungen (DiGA), remove financial barriers for patients seeking treatment. Doctors can prescribe them like traditional medicines, making access easier than ever before.

The shift comes as Germany's ageing population and digital advancements increase demand for flexible therapy options. Unlike commercial brain-training apps, DiGA programs are evidence-based and reviewed by the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). One approved app, NeuroNation MED, proved its effectiveness in a study of 288 participants, outperforming standard care.

Accessing these therapies is simple. After a diagnosis, a doctor issues a prescription, and the insurer provides an activation code. Patients then use the app free of charge for the first 90 days. Apps like Memodio adjust exercise difficulty to match individual cognitive abilities, offering tailored support.

Beyond dementia care, these tools also help post-COVID patients with cognitive deficits. In the future, artificial intelligence and digital assessments could make them even more precise. The growing list of approved DiGA options reflects a broader move toward clinically backed digital treatments.

The expansion of insurer-covered digital therapies provides more people with affordable, research-backed cognitive support. With an ageing society and limited traditional therapy slots, these programs offer a practical alternative. Patients can now access personalised treatment without upfront costs, following a doctor's prescription.